Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC: a Multicenter Analysis

NCT06737367 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT06737367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06737367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC: a Multicenter Analysis
Lead sponsor
Jinling Hospital, China
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
November 11, 2024
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer - non small cell